VIELA BIO

A clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases by selectively targeting shared critical pathways that are the root cause of disease

Learn More

Our Portfolio

Viela Bio is building a portfolio of innovative biologics that either are first in class or have the potential to be best in class

Our Team

Viela Bio is led by a team of motivated industry experts, aiming to make a difference for inflammation and autoimmunity patients

Our Recent News

Viela Bio Spins Out of MedImmune

| Company General News | No Comments
Viela Bio team will focus on developing medicines for severe autoimmune diseases by targeting critical pathways that are the root cause of disease Gaithersburg, MD, February 28, 2018 – Viela…